Across TCGA pan-cancer cohorts, SGMS1-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated SGMS1-AS1 data layer compared with 3 for mutation status.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SGMS1-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SGMS1-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and MESO show a favorable association.
KIRC, MESO, and BRCA are the cancer types where SGMS1-AS1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.